![William Campbell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Campbell
No más puestos en curso
Perfil
William Campbell served as Chairman at Kinexus Bioinformatics Corp.
and as Director & Chief Scientific Officer at Regenerex Pharma, Inc. He received his undergraduate degree from Concordia University in 1962 and his doctorate degree from the University of Montréal in 1971.
Antiguos cargos conocidos de William Campbell.
Empresas | Cargo | Fin |
---|---|---|
Kinexus Bioinformatics Corp.
![]() Kinexus Bioinformatics Corp. Packaged SoftwareTechnology Services Kinexus Bioinformatics Corp. provides specialized proteomics services for tracking protein kinases and other cell signaling proteins. The firm maps and monitors the molecular communications networks of living cells for biomedical research into the diagnosis, prognosis and treatment of human diseases. The firm offers cell culture, kinase-substrate profiling, kinase-inhibitor profiling, mass spectrometry, protein & peptide production, custom graphics, technical support and data security services. The company was founded by Steven Pelech on July 30, 1999 and is headquartered in Vancouver, Canada. | Presidente | - |
PEPTIDE TECHNOLOGIES INC | Director Técnico/Científico/I+D | - |
Formación de William Campbell.
Concordia University | Undergraduate Degree |
University of Montréal | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PEPTIDE TECHNOLOGIES INC | Health Technology |
Empresas privadas | 1 |
---|---|
Kinexus Bioinformatics Corp.
![]() Kinexus Bioinformatics Corp. Packaged SoftwareTechnology Services Kinexus Bioinformatics Corp. provides specialized proteomics services for tracking protein kinases and other cell signaling proteins. The firm maps and monitors the molecular communications networks of living cells for biomedical research into the diagnosis, prognosis and treatment of human diseases. The firm offers cell culture, kinase-substrate profiling, kinase-inhibitor profiling, mass spectrometry, protein & peptide production, custom graphics, technical support and data security services. The company was founded by Steven Pelech on July 30, 1999 and is headquartered in Vancouver, Canada. | Technology Services |
- Bolsa de valores
- Insiders
- William Campbell